farnesol has been researched along with Cardiotoxicity in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Alkhanjaf, AAM; Alsayhab, AMH; Athar, MT; Shaikh, IA; Ullah, Z; Umar, A | 1 |
1 other study(ies) available for farnesol and Cardiotoxicity
Article | Year |
---|---|
Farnesol Protects against Cardiotoxicity Caused by Doxorubicin-Induced Stress, Inflammation, and Cell Death: An In Vivo Study in Wistar Rats.
Topics: Animals; Antioxidants; Cardiotoxicity; Cell Death; Doxorubicin; Farnesol; Inflammation; Male; Myocytes, Cardiac; Oxidative Stress; Quality of Life; Rats; Rats, Wistar | 2022 |